ABI
AGN

Adamant Biomedical Investments’s Allergan plc AGN Stock Holding History

Adamant Biomedical Investments’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$13.3M Sell
51,590
-520
-1% -$130K 3.17% 5
2014
Q3 		$12.6M Buy
+52,110
New +$11.7M 3.14% 5

Other funds holding AGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Adamant Biomedical Investments's AGN Position: Q4 2014 in Review

Adamant Biomedical Investments reduced its Allergan plc (AGN) stake by 1% in Q4 2014, selling an estimated $130K and leaving 51,590 shares worth $13.3M. The position accounts for 3.17% of the portfolio, ranked #5.

Adamant Biomedical Investments first reported a position in AGN in Q3 2014 and has held it in 2 quarters since. 840 funds tracked by Wall St. Rank hold AGN as of Q4 2014.

  • Adamant Biomedical Investments held 51,590 shares of Allergan plc worth $13.3M as of Q4 2014.
  • Adamant Biomedical Investments sold 520 Allergan plc shares in Q4 2014, an estimated $130K.
  • Allergan plc made up 3.17% of Adamant Biomedical Investments's portfolio in Q4 2014, its #5 holding.
  • Adamant Biomedical Investments first reported a position in Allergan plc in Q3 2014 and has held it in 2 quarters since.
  • 840 funds tracked by Wall St. Rank held Allergan plc as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.